Login
From:
Synox | Website
(Uncensored)
subscribe
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
https://synoxtherapeutics.com/synox-therapeutics-completes-enrollment-in-registrational-phase-3-tangent-clinical-trial-significantly-ahead-of-timeline/
links
backlinks
Tagged with:
press releases
emactuzumab
synox
synox therapeutics
tangent
Top-Line Results from Study Evaluating Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) Expected in First Quarter of 2026
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
